RADx℠ Tech and ATP Programs

The RADx Tech/ATP programs are components of the overarching RADx Initiative at NIH to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. The RADx Tech/ATP innovation funnel was designed to compress the customary technology development timeline from years down to just months.  This was accomplished by employing, in parallel, expert teams to address technical, regulatory, clinical, and commercialization requirements. Launched on April 29, 2020, the RADx programs were able to validate, de-risk, scale up, manufacture, and deploy novel tests through a seamless pipeline by fall 2020. A new solicitation was launced in June 2021 is seeking additonal technologies to meet unmet needs. 

coronavirus with blue background

RADx Tech II Launches

NIBIB is soliciting proposals to further advance SARS-CoV-2 testing technologies to fill specific unmet national needs.  Unmet needs include but are not limited to:

  • Point-of-care/over-the-counter tests with lab performance
  • Tests for multiple pathogens
  • Tests adaptable to emerging variants
  • Solicitation will only consider proposals for technologies in an advanced stage of readiness that can reach the market in 2021

Application period is June 7-28, 2021.

Information and how to apply can be found on the POCTRN website. Please refer to RADx Tech II FAQs

generic bar chart titled tests produced

Program Dashboard

Summary data on proposals submitted to the RADx Tech and ATP Programs.

  • 300 million tests produced 
  • 150 companies supported
  • 23 FDA authorizations
colorful timeline arranged as steps toward a large arrow on the right

RADx Tech Timeline

See the milestones and success that have unfolded since the beginning of the RADx Tech program.

RADx Tech organization chart


The RADx Tech and ATP programs leverage the Point of Care Technology Research Network and joined with numerous other federal agencies, offices, NIH institutes, and contractors.

RADx Testing

Tests in Development

Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.

Learn about the COVID-19 Testing Impact Calculator, a tool to help organizations plan for and demonstrate how testing and other mitigation measures can curb the spread of the virus. The tool includes a K-12 playbook to help provide guidance for school administrators and an Implementation Guide for any organization developing a testing strategy.

This webinar series hosted by POCTRN provides information on RADx Tech/ATP program activities.  Register for upcoming events or watch previous webinars.


View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.

Information about studies to evaluate diagnostic tests being developed for COVID-19.

Program Contacts

Program Contacts

Current grantees contact Program Director on your existing award.

RADx℠ Tech programmatic or technical inquiries: info.radx@poctrn.org

All other RADx℠ Tech Applicants: RADxNIBIB@mail.nih.gov 

SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov 

All others: COVID19NIBIB@nibib.gov 

Related Resources

Related News

June 1, 2021
Unlike many other viral testing platforms, MatMaCorp’s all-in-one Solas 8 testing device provides results for six samples in 120 minutes and doesn’t require the additional lab support often lacking in rural areas. To help make the pivot to the human health market, the company applied to the NIH RADx initiative, Source: VentureWell
May 28, 2021
Thinking back to a year ago when terror struck worldwide and the full weight of the Covid-19 pandemic began to set in, NIH quickly mobilized on multiple fronts—one of which was the RADx initiative, with the goal of helping to meet the huge demand for fast, accurate Covid-19 tests. Source: NIH Record.
April 29, 2021
word cloud
One-year into implementation of the NIH RADx initiative, the IEEE Open Journal of Engineering in Medicine and Biology has dedicated a specialissue to exploring the innovative structure and operation of the RADx Tech program.
April 23, 2021
gloved hand placing cartridge into blue instrument
The National Institutes of Health (NIH) today announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel COVID-19 testing technologies.
April 15, 2021
Greenlight Guru, the medtech industry's leading medical device quality management software (MDQMS) platform, today announced its selection as the premier QMS for the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program, led by the National Institute of Biomedical Imaging and Bioengineering. This program aims to improve the speed of innovation in the development, commercialization and implementation of technologies for COVID-19 testing. Source: Prnewswire